Sinew Pharma (ROCO:6634) Marketable Securities : NT$1,136.69 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sinew Pharma's Marketable Securities for the quarter that ended in Jun. 2023 was NT$1,136.69 Mil.

Sinew Pharma's annual Marketable Securities increased from Dec. 2020 (NT$291.49 Mil) to Dec. 2021 (NT$931.49 Mil) and increased from Dec. 2021 (NT$931.49 Mil) to Dec. 2022 (NT$1,144.49 Mil).

Sinew Pharma Marketable Securities Historical Data

The historical data trend for Sinew Pharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Marketable Securities Chart

Sinew Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

81.20

39.99

291.49

931.49

1,144.49

Sinew Pharma Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Marketable Securities	Get a 7-Day Free Trial												271.49	931.49	1,101.49	1,144.49	1,136.69

Sinew Pharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Sinew Pharma (ROCO:6634) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sinew Pharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinew Pharma (ROCO:6634) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571

Website

https://www.sinewpharma.com

Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines